Investors & Media
About
Our Science
Our Programs
Careers
Investors & Media
Stockholder Tools
Global - Contact
Investor Contact
Ronald Aldridge
Constellation Pharmaceuticals
+1-617-714-0539
ron.aldridge@constellationpharma.com
Media Contact
Lauren Arnold
MacDougall Biomedical Communications
+1-781-235-3060
larnold@macbiocom.com
SEC Filing
SEC Filing Details
Document Details
Form
Filing Date
Nov 30, 2018
Document Date
Nov 28, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Constellation Pharmaceuticals
Issuer
CONSTELLATION PHARMACEUTICALS INC
Filer
Trojer Patrick
Investors & Media
About
Our Science
Our Programs
Careers
Investors & Media
Stockholder Tools
Investor Contact
Ronald Aldridge
Constellation Pharmaceuticals
+1-617-714-0539
ron.aldridge@constellationpharma.com
Media Contact
Lauren Arnold
MacDougall Biomedical Communications
+1-781-235-3060
larnold@macbiocom.com